Curaleaf (OTCMKTS:CURLF) Shares Up 9.3% – Still a Buy?

Curaleaf Holdings, Inc. (OTCMKTS:CURLF) shares traded up 9.3% during trading on Monday. The stock traded as high as $9.18 and last traded at $9.04. 106,001 shares changed hands during mid-day trading, a decline of 62% from the average session volume of 281,288 shares. The stock had previously closed at $8.27.

Analyst Ratings Changes

A number of research firms recently commented on CURLF. Zacks Research cut shares of Curaleaf from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, October 13th. UBS Group set a $6.00 target price on shares of Curaleaf in a research report on Monday, October 5th. Finally, Citigroup reissued a “buy” rating on shares of Curaleaf in a research report on Thursday, August 6th. One research analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating and one has given a Hold rating to the stock. According to MarketBeat, Curaleaf presently has a consensus rating of “Buy” and an average target price of $6.00.

Curaleaf Price Performance

The stock’s fifty day moving average price is $9.56 and its 200-day moving average price is $8.31. The firm has a market cap of $2.24 billion, a price-to-earnings ratio of -73.83 and a beta of 1.62. The company has a current ratio of 1.52, a quick ratio of 0.73 and a debt-to-equity ratio of 1.06.

Curaleaf (OTCMKTS:CURLF) last released its quarterly earnings results on Tuesday, November 3rd. The company reported ($0.14) EPS for the quarter, topping analysts’ consensus estimates of ($0.16) by $0.02. Curaleaf had a negative return on equity of 0.88% and a negative net margin of 2.62%. The company had revenue of $352.65 million for the quarter, compared to analysts’ expectations of $346.46 million. As a group, equities research analysts forecast that Curaleaf Holdings, Inc. will post 0.01 earnings per share for the current fiscal year.

Curaleaf Company Profile

Curaleaf Holdings, Inc is a cannabis company that cultivates, processes, distributes and sells cannabis products for medical and adult-use markets. Its portfolio includes cannabis flower, pre-rolls, vaporizers, concentrates, edibles, tinctures, capsules, topicals and other wellness products, offered under brands such as Curaleaf, Select and Grassroots.

The company serves customers through a network of retail dispensaries and wholesale channels in regulated U.S. cannabis markets. Its operations include cultivation and manufacturing facilities as well as dispensaries, with products distributed in multiple states where medical or adult-use cannabis is permitted.